Robert G Aslanian

This inventor holds 58 USPTO granted patents and 31 published patent applications and 14 EPO patents, primarily in Pharmaceutical Compounds (CPC class C07D). Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Schering-Plough Corporation. Active years: 1995-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert G Aslanian. Retrieved from https://idiyas.com/inventor/robert-g-aslanian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 58 (Patent Applications = 31)

% Patents Active = 37.9

EPO Patents = 14 (Patent Applications = 41)

Average Co-Inventor Count = 6.1

ph-index = 13

Forward Citations = 448(Granted Patents)

Forward Citations (Not Self Cited) = 390(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

Merck Sharp + Dohme Corp.

patents

3 out of 28

Schering-Plough Corporation

patents

4. 2 out of 52

Pharmacopeia Drug Discovery, Inc.

patents

5. 1 out of 97

Albany Molecular Research, Inc.

7. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2020

Loading Chart...

Areas of Expertise:

A2A Antagonists

Diacylglycerol Inhibitors

Glucocorticoid Receptor Agonists

Alpha2C Adrenergic Receptor Modulators

Gamma Secretase Modulators

Heterocycles

Histamine H3 Antagonists

Piperidine Compounds

Aminopyrazine Compounds

Bicyclic Compounds

Fused Tricyclic Compounds

Nitrogen-Containing Compounds

58 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10688082 - Aminopyrazine compounds with A2A antagonist properties (2020-06-23),

2. 9469615 - [object Object] (2016-10-18),

3. 9290453 - [object Object] (2016-03-22),

4. 8927559 - [object Object] (2015-01-06),

5. 8716312 - Inhibitors of diacylglycerol acyltransferase (2014-05-06),

6. 8637507 - Bicyclic compounds as inhibitors of diacylglycerol acyltransferase (2014-01-28),

7. 8598158 - Fused tricyclic compounds for the treatment of inflammatory disorders (2013-12-03),

8. 8592383 - [object Object] (2013-11-26),

9. 8569312 - Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators (2013-10-29),

10. 8524697 - C20-C21 substituted glucocorticoid receptor agonists (2013-09-03),

11. 8518975 - Gamma secretase modulators (2013-08-27),

12. 8501747 - Functionally selective alpha2C adrenoreceptor agonists (2013-08-06),

13. 8476274 - Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators (2013-07-02),

14. 8470863 - Derivatives and analogs of chroman as functionally selective ALPHA2C adrenoreceptor agonists (2013-06-25),

15. 8450343 - Gamma secretase modulators (2013-05-28),

Title: The Inventor Robert G Aslanian: Pioneering Innovations in Rockaway, NJ

Introduction: Robert G Aslanian is a distinguished inventor based in Rockaway, NJ, known for his groundbreaking contributions to various fields.

Latest Patents: Robert G Aslanian holds several patents in the areas of technology and engineering, showcasing his continuous commitment to innovation.

Career Highlights: With a career spanning over two decades, Robert G Aslanian has established himself as a visionary inventor, with a keen eye for identifying gaps in the market and developing unique solutions.

Collaborations: Throughout his career, Robert G Aslanian has collaborated with leading companies and research institutions, fostering a culture of innovation and knowledge-sharing.

Conclusion: Robert G Aslanian's passion for innovation and his relentless drive to push boundaries make him a prominent figure in the world of inventors, leaving a lasting impact on the industry.

Profile summary based on public USPTO records.